Kaiser Franz Josef Hospital Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4
Founded: Vienna Austria (1996)

Organization Overview

First Clinical Trial
1999
NCT00003980
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Center for Oncology and Hematology Kaiser Franz Josef Hospital - Vienna - Austria | Kaiser Franz Josef Hospital | Ludwig Boltzmann Institute for Applied Cancer Research at Kaiser Franz Josef Hospital

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Arteriosclerosis (Phase 4)

Breast Neoplasms (Phase 2)

Carcinoma (Phase 2)

Carcinoma, Transitional Cell (Phase 2)

Coronary Artery Disease (Phase 4)

Coronavirus Infections (Phase 3)

Myocardial Ischemia (Phase 4)

Neoplasms (Phase 1)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 6
  • # of Trial APIs: 16